Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes Clinical research trials and Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes. Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.

Home > "S" Clinical Trials Conditions > Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes

Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes



Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes

For Condition: Sickle Cell Anemia
Status: Recruiting
Sponsor(s): FDA Office of Orphan Products Development , Children's Hospital Boston
Synopsis: OBJECTIVES: Determine the effectiveness of the combined use of clotrimazole and hydroxyurea on a specific panel of red cell characteristics in patients with sickle cell syndromes.
Details: PROTOCOL OUTLINE: Patients receive oral hydroxyurea either once or twice daily plus oral clotrimazole twice daily after meals for 6 months. Patients are assessed at 3 and 6 months during treatment.
Eligibility:
Study Type:  Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Sickle cell syndromes characterized by vaso-occlusive crises sufficiently severe to require prophylactic therapy Three or more crises per year sufficiently severe to require hospitalization Stable dose of hydroxyurea for at least 4 months required --Prior/Concurrent Therapy-- No treatment with any other antisickling agents within the past 4 months Biologic therapy: No transfusion within 90 days No concurrent chronic transfusions allowed (defined as more than one transfusion per month for 2 or more months) Chemotherapy: See Disease Characteristics Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: Not specified Other: No chronic medications that alter neurologic, renal, or hepatic functions --Patient Characteristics-- Performance status: Karnofsky 70-100% Hematopoietic: WBC within normal limits Platelet count within normal limits Hepatic: No history of chronic liver disease Bilirubin less than 2 times normal SGOT and SGPT less than 2.5 times normal No severe hepatic damage Renal: Creatinine within normal limits No severe renal damage Neurologic: No severe neurologic impairment No recent or progressive neurologic impairment Other: Not pregnant Fertile patients must use effective contraception No allergies to hydroxyurea or clotrimazole
Total Enrollment: 20

Location and Contact Information:

Overall Study Official:
CarloBrugnara,  Study Chair,  Children's Hospital Boston

Brigham and Women's Hospital *Recruiting*
Boston,  Massachusetts,  02115
United States
Recruiting Kenneth  Bridges 617-432-1000

Children's Hospital - Boston *Recruiting*
Boston,  Massachusetts,  02115
United States
Recruiting Carlo  Brugnara 617-355-6347


Additional Information:
Study ID Numbers:  199/13288;  CH-B-97-052,CH-B-FDR001022
Study Start Date: April 1997
Record last reviewed: May 1998
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004404

Other Sickle Cell Anemia Studies:
1. Bone Marrow transplant from related donor for patients with high risk hemoglobinopathies

2. Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes

3. A study of the efficacy and safety of ICA-17043 (with or without hydroxyurea) in patients with sickle cell anemia.

4. Nitric Oxide to Improve Blood Flow in Sickle Cell Disease

5. A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients with Sickling Disorders

Related Studies:

Other Sickle Cell Anemia Clinical Trials
Other Massachusetts Clinical Trials
Other Boston Clinical Trials

Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes
Modify your Search

  Other Sickle Cell Anemia Clinical Trials
  Other Massachusetts Clinical Trials
  Other Boston Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103